Committee on Biotechnology Products (2003e2011) of the MHLW's Council, and has been chairing Expert Committee on Genetically Modified Foods (2003e2007) and followed by the Planning Expert Committee of the Food Safety Commission of Japan. He also chaired the Japanese Biologics Forum (2005e2011). One of his current activities is to develop draft guidance on ensuring quality and safety of stem cell derived products for therapeutic use. Characterization and utilization of pluripotent stem cells for medical and pharmaceutical researches are the subjects of his special interest.
Congratulation! and we are proud of him. I declare that Masayuki Yamato is a shareholder of CellSeed Inc.
Masayuki Yamato 
